Detalus Advisors, LLC Abbott Laboratories Transaction History

Detalus Advisors, LLC

$287 Million
Q3 2024

A detailed history of Detalus Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Detalus Advisors, LLC holds 15,275 shares of ABT stock, worth $1.8 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

15,275

Previous 15,275 -0.0%

Holding current value

$1.8 Million

Previous $1.59 Million 9.7%

% of portfolio

0.61%

Previous 0.57%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $34,953 - $39,016	-347 Reduced 2.22%	15,275 $1.59 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $1,803 - $2,208	-20 Reduced 0.13%	15,622 $1.72 Million
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $93,619 - $112,327	-980 Reduced 5.9%	15,642 $1.51 Million
Q2 2023 Jul 28, 2023	BUY	$100.78 - $112.29 $38,699 - $43,119	384 Added 2.36%	16,622 $1.81 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $4,164 - $4,902	-43 Reduced 0.26%	16,238 $1.64 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $1.34 Million - $1.58 Million	14,136 Added 659.02%	16,281 $1.79 Million
Q2 2022 Jul 27, 2022	SELL	$102.07 - $123.37 $59,710 - $72,171	-585 Reduced 21.43%	2,145 $233,000
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $34,206 - $41,712	-300 Reduced 9.9%	2,730 $323,000
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $90,575 - $110,904	-784 Reduced 20.56%	3,030 $426,000
Q3 2021 Oct 20, 2021	SELL	$116.66 - $129.06 $5,249 - $5,807	-45 Reduced 1.17%	3,814 $451,000
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $11,848 - $13,947	-112 Reduced 2.82%	3,859 $447,000
Q1 2021 Apr 15, 2021	SELL	$108.84 - $128.23 $27,210 - $32,057	-250 Reduced 5.92%	3,971 $476,000
Q4 2020 Jan 19, 2021	SELL	$105.0 - $114.42 $3,570 - $3,890	-34 Reduced 0.8%	4,221 $462,000
Q3 2020 Nov 18, 2020	BUY	$91.64 - $111.29 $74,686 - $90,701	815 Added 23.69%	4,255 $463,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $4,211 - $5,390	55 Added 1.62%	3,440 $315,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $314 - $459	5 Added 0.15%	3,385 $267,000
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $265,363 - $295,412	3,380 New	3,380 $294,000

Others Institutions Holding ABT

# of Institutions

3,202

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.

Account

Detalus Advisors, LLC Abbott Laboratories Transaction History